info@seagull-health.com
SeagullHealth
语言:
search

Vosevi(Sofosbuvir/Velpatasvir/Voxilaprevir) Side Effects

A description of the most common and serious adverse reactions associated with the drug.

Adverse Reactions

The most common adverse reactions (occurring in ≥10% of patients) during 12 weeks of treatment with VOSEVI were headache, fatigue, diarrhea, and nausea. Most of these events were mild to moderate in severity. Serious adverse reactions include the risk of hepatitis B virus (HBV) reactivation in coinfected patients, hepatic decompensation in patients with advanced liver disease, and serious symptomatic bradycardia when coadministered with amiodarone.

Sofosbuvir/Velpatasvir/Voxilaprevir(Vosevi)
Sofosbuvir/Velpatasvir/Voxilaprevir(Vosevi)
Treatment of chronic HCV infection in adults without cirrhosis or with...
WeChat Scan
Free Inquiry
Related articles
共 0 条
  • 1
前往
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved